| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8673975 | Mayo Clinic Proceedings | 2017 | 16 Pages |
Abstract
The RCTs offer substantial evidence about the common effects of drugs on the risk of sleep disturbance; currently, prescription information only partially agrees with the available randomized evidence.
Keywords
DOPAN-methyl-d-aspartic acidNMDASNRIRCTIQRMAOIPDRCatechol-O-Methyltransferase inhibitorTCAFDANSAIDGnRHRandomized controlled trialγ-aminobutyric acidnonsteroidal anti-inflammatory drugTricyclic antidepressantDopamineFood and Drug Administrationadverse eventinterquartile rangeSelective serotonin reuptake inhibitorserotonin-norepinephrine reuptake inhibitormonoamine oxidase inhibitorSSRIodds ratioGonadotropin-releasing hormoneGABA
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Anthony G. MD, PhD, Orestis A. MD, PhD, Periklis MD, Shane Shucheng MD, John P.A. MD, DSc,